Total Payments
$7,083
2024 Payments
$1,153
Companies
35
Transactions
308
Medicare Patients
4,385
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$6,984 (98.6%)
Education$99.00 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,984 | 307 | 98.6% |
| Education | $99.00 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,671 | 88 | $0 (2024) |
| Lilly USA, LLC | $914.85 | 32 | $0 (2024) |
| GENZYME CORPORATION | $437.25 | 21 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $406.67 | 12 | $0 (2024) |
| Celgene Corporation | $348.56 | 20 | $0 (2019) |
| Janssen Biotech, Inc. | $345.45 | 8 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $334.61 | 8 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $322.56 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $204.18 | 6 | $0 (2021) |
| Galderma Laboratories, L.P. | $192.02 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,153 | 51 | GENZYME CORPORATION ($212.37) |
| 2023 | $1,053 | 43 | AbbVie Inc. ($217.18) |
| 2022 | $1,101 | 47 | ABBVIE INC. ($327.50) |
| 2021 | $517.40 | 28 | AbbVie Inc. ($199.98) |
| 2020 | $145.67 | 8 | Lilly USA, LLC ($42.83) |
| 2019 | $868.28 | 38 | AbbVie, Inc. ($335.64) |
| 2018 | $1,380 | 60 | AbbVie, Inc. ($348.38) |
| 2017 | $864.25 | 33 | Celgene Corporation ($158.77) |
All Payment Transactions
308 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Immunology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.83 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.22 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Immunology | ||||||
| 11/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Immunology | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.92 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Immunology | ||||||
| 11/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: DERMATOLOGY | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| Category: Immunology | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Immunology | ||||||
| 09/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Immunology | ||||||
| 09/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Dermatology | ||||||
| 08/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $124.69 | General |
| Category: Dermatology | ||||||
| 08/19/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,097 | 1,566 | $569,421 | $298,468 |
| 2022 | 30 | 1,121 | 1,551 | $654,758 | $344,720 |
| 2021 | 25 | 1,131 | 1,630 | $577,949 | $327,799 |
| 2020 | 22 | 1,036 | 1,380 | $554,358 | $305,375 |
Total Patients
4,385
Total Services
6,127
Medicare Billing
$1.3M
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 205 | 299 | $243,471 | $120,034 | 49.3% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 125 | 232 | $115,203 | $74,200 | 64.4% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 26 | 36 | $26,992 | $14,558 | 53.9% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 13 | 14 | $16,739 | $10,904 | 65.1% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 18 | 18 | $16,732 | $10,073 | 60.2% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 41 | 43 | $24,797 | $8,238 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 107 | 128 | $13,598 | $7,665 | 56.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 96 | 107 | $12,573 | $6,804 | 54.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 27 | 28 | $10,432 | $5,089 | 48.8% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Office | 2023 | 40 | 58 | $6,869 | $4,732 | 68.9% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 20 | 22 | $12,675 | $4,575 | 36.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 40 | 100 | $5,805 | $3,983 | 68.6% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 20 | 23 | $11,540 | $3,785 | 32.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 41 | 41 | $5,311 | $3,282 | 61.8% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 22 | 25 | $10,037 | $3,046 | 30.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 33 | 36 | $5,197 | $2,787 | 53.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 54 | 71 | $5,696 | $2,451 | 43.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 26 | $5,298 | $2,444 | 46.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 19 | 24 | $2,765 | $1,776 | 64.2% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 12 | 12 | $4,598 | $1,743 | 37.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 14 | $4,250 | $1,472 | 34.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 38 | $2,548 | $1,455 | 57.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 13 | $2,131 | $1,264 | 59.3% |
| 69100 | Biopsy of ear | Office | 2023 | 16 | 21 | $2,374 | $1,047 | 44.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $989.17 | $570.17 | 57.6% |
About Dr. Daniel Witheiler, M.D
Dr. Daniel Witheiler, M.D is a MOHS-Micrographic Surgery healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023083482.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Witheiler, M.D has received a total of $7,083 in payments from pharmaceutical and medical device companies, with $1,153 received in 2024. These payments were reported across 308 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($6,984).
As a Medicare-enrolled provider, Witheiler has provided services to 4,385 Medicare beneficiaries, totaling 6,127 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location Dallas, TX
- Active Since 02/21/2006
- Last Updated 08/01/2023
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1023083482
Products in Payments
- TALTZ (Drug) $785.65
- SKYRIZI (Biological) $696.92
- Humira (Biological) $630.25
- DUPIXENT (Biological) $555.40
- Otezla (Drug) $398.68
- TREMFYA (Drug) $387.66
- Zoryve (Drug) $192.89
- COSENTYX (Biological) $180.47
- RINVOQ (Biological) $172.32
- Sotyktu (Drug) $164.37
- DORYX (Drug) $156.84
- Ameluz (Drug) $146.08
- PICATO (Drug) $126.36
- DUPIXENT DUPILUMAB INJECTION (Biological) $123.76
- SPEVIGO (Drug) $123.09
- Erivedge (Biological) $109.18
- ILUMYA (Biological) $98.03
- HUMIRA (Biological) $87.56
- ORACEA (Drug) $78.20
- Seysara (Drug) $74.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
MOHS-Micrographic Surgery Doctors in Dallas
Dr. Thornwell Parker, M.d, M.D
MOHS-Micrographic Surgery — Payments: $12,508
MOHS-Micrographic Surgery $12,508
Christine Brown, M.d, M.D
MOHS-Micrographic Surgery — Payments: $7,848
MOHS-Micrographic Surgery $7,848
Dr. Rajiv Nijhawan, M.d, M.D
MOHS-Micrographic Surgery — Payments: $177.50
MOHS-Micrographic Surgery $177.50
Dr. Frank Saporito, M.d, M.D
MOHS-Micrographic Surgery — Payments: $107.86
MOHS-Micrographic Surgery $107.86
Sarah Felton
MOHS-Micrographic Surgery
MOHS-Micrographic Surgery